(PharmaNewsWire.Com, June 27, 2023 ) The report "Digital Twins in Healthcare Market by Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2028", is projected to reach USD 21.1 billion by 2028 from USD 1.6 billion in 2023, at a high CAGR of 67.0% during the forecast period.
Rise in investments & funding in the digital twin market supporting the growing number of startups, And increasing focus on cutting-edge real-time analytics are some of the key factors that offer opportunities to the market during the forecast period. However, the obsolete digital infrastructure and the reluctance towards the use of new technologies are challenging the market growth to some extent.
The research and Academia segment is expected to register a substantial growth in the digital twins in healthcare market, by end user
The research and academia segment is expected to register a substantial growth in the digital twins in healthcare market, by end user. This growth can be attributed to their ability to drive technological advancements in the healthcare sector, collaborative research efforts within these institutions fostering knowledge sharing & enhance patient care outcomes, availability of extensive healthcare data & the expertise to analyze and model it give research institutions a competitive edge in leveraging digital twins effectively. Lastly, the inclination of academic institutions to explore emerging technologies positions them as early adopters and catalysts for growth in the digital twins in healthcare market.
APAC is to witness a considerable growth rate during the forecast period.
The Asia Pacific market is projected to grow at a considerable CAGR during the forecast period. Factors such as increasing medical tourism, growing investments expected to bring about the creation of new market participants, growing prevalence of various technologies such as IoT, machine learning, etc., and the rising geriatric population are anticipated to drive the development of digital twins for healthcare applications in the Asia Pacific region.
Siemens Healthineers AG (Germany), Dassault Systèmes (France), Microsoft (US), Koninklijke Philips N.V. (Netherlands), Faststream Technologies (US), Twin LTD (US), IBM (US), NVIDIA Corporation (US), GE Healthcare (US), NUREA (France), ANSYS, Inc. (US), Rescale, Inc. (US), Predictiv (US), Verto Health (Canada), PrediSurge (France), Qbio (US), Virtonomy GmbH (Germany), Unlearn AI (US), Atos SE (France), ThoughtWire (Canada), Amazon Web Services, Inc.(US), Oracle(US), PTC (US), SAP (Germany), Sim and Cure (France) are the major players in this market. These companies are majorly focusing on the strategies such as agreements, collaborations, partnerships, and service launches in order to remain competitive and further increase their share in the market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
